1-9 of 9
R McCaffrey
Close
Sort by
Journal Articles

2005 Update on Accelerated FDA Approval of Drugs Used To Treat Hematologic Malignancies from the Research on Adverse Drug-Events and Reports (RADAR): Rate of Regular Approval Conversion Remains Low.

Charles L. Bennett, MD, PhD, MPP, Jessica A. Zagory, BA, June M. McKoy, MD, MPH, JD, Kathryn R. McCaffrey, BA, E. Allison Lyons, BA, Steven Belknap, MD
Journal: Blood
Blood (2005) 106 (11): 289.
https://doi.org/10.1182/blood.V106.11.289.289
Published: 2005
Journal Articles

National Responses to HIV Versus HCV-Infection from Virally Contaminated Blood Products among Persons with Hemophilia (PWH): More Different Than Alike.

Charles L. Bennett, MD, PhD, MPP, Lauren E. Frohlich, Kathryn R. McCaffrey, BA, June M. McKoy, MD, MPH, JD, Glenn E. Ramsey, MD, Julia S. Lindenberg, BA
Journal: Blood
Blood (2005) 106 (11): 3213.
https://doi.org/10.1182/blood.V106.11.3213.3213
Published: 2005
Journal Articles

ADAMTS13 Levels Support Hypothesis of Distinct Mechanistic Pathways for Early Versus Late-Onset of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP).

H.C. Kwaan, MD, PhD, June M. McKoy, MD, MPH, JD, Kathryn R. McCaffrey, BA, Paul R. Yarold, PhD, Benjamin Kim, MD, Anaadriana Zakarija, MD, Nicholas Bandarenko, MD, Dilip K. Pandey, MD, PhD, James N. George, MD, X. Long Zheng, MD, PhD, Kenneth R. Carson, MD, Charles L. Bennett, MD, PhD, MPP
Journal: Blood
Blood (2005) 106 (11): 60.
https://doi.org/10.1182/blood.V106.11.60.60
Published: 2005
Journal Articles

Incident TTP: Plasmapheresis Therapy-Related Complications Are Common.

Anaadriana Zakarija, MD, Kathryn R. McCaffrey, BA, Nicholas Bandarenko, MD, Dilip Pandey, MD, PhD, John Cursio, MS, Amul Tevar, MPH, Hau Kwaan, MD, PhD, Paul R. Yarnold, PhD, Maddie Burton, Charles L. Bennett, MD, PhD, MPP
Journal: Blood
Blood (2005) 106 (11): 1254.
https://doi.org/10.1182/blood.V106.11.1254.1254
Published: 2005
Journal Articles

Developing National Estimates of the Out-of-Pocket Costs of Cancer: The Importance of Including Patients with Lymphoma.

Kathryn R. McCaffrey, B.A., Kenneth R. Carson, MD, Lucie Kutikova, Ph.D., Matt Fisher, Simon Pickard, Ph.D., Glen Schumock, PharmD, MBA, Lee Bowman, Ph.D., Charles L. Bennett, MD, Ph.D., MPP
Journal: Blood
Blood (2004) 104 (11): 3138.
https://doi.org/10.1182/blood.V104.11.3138.3138
Published: 2004
Journal Articles

2',3'-Dideoxyadenosine is selectively toxic for TdT-positive cells

Z Spigelman, R Duff, GP Beardsley, S Broder, D Cooney, NR Landau, H Mitsuya, B Ullman, R McCaffrey
Journal: Blood
Blood (1988) 71 (6): 1601–1608.
https://doi.org/10.1182/blood.V71.6.1601.1601
Published: 1988
Journal Articles

Characterization of glucocorticoid receptors in animal lymphoblastic disease: correlation with response to single-agent glucocorticoid treatment

R Bell, S Cotter, A Lillquist, S Sallan, R McCaffrey
Journal: Blood
Blood (1984) 63 (2): 380–383.
https://doi.org/10.1182/blood.V63.2.380.380
Published: 1984
Journal Articles

Abnormal glucocorticoid receptors in acute leukemia cells

R McCaffrey, A Lillquist, R Bell
Journal: Blood
Blood (1982) 59 (2): 393–400.
https://doi.org/10.1182/blood.V59.2.393.393
Published: 1982
Journal Articles

Biochemical and biophysical characterization of glucocorticoid receptors in normal lymphoid tissue

R McCaffrey, A Lillquist, R Bell
Journal: Blood
Blood (1981) 58 (2): 263–267.
https://doi.org/10.1182/blood.V58.2.263.263
Published: 1981